Transanal total mesorectal excision: the Slagelse experience 2013-2019

Sharaf Karim Perdawood1, Jens Kroeigaard2, Marianne Eriksen2

  • 1Department of Gastrointestinal Surgery, Slagelse Hospital, Faelledvej 11, 4200, Slagelse, Denmark. sharaf73@hotmail.com.

Surgical Endoscopy
|February 20, 2020
PubMed
Summary

Transanal total mesorectal excision (TaTME) shows acceptable short-term outcomes for rectal cancer, with a 4.7% local recurrence rate. Longer follow-up is needed to confirm long-term oncologic results after this minimally invasive procedure.